newsfilter
← Latest News
Business Wire·

Forma Therapeutics to Participate in Upcoming Investor Conferences

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that company management will participate in two upcoming investor conferences: The Oppenhe